Royal Bank of Canada
ACLX

Royal Bank of Canada’s Arcellx ACLX Stock Holding History

Royal Bank of Canada’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7K Sell
59
-951
-94% -$83.9K ﹤0.01% 6293
2025
Q4 		$66K Sell
1,010
-61,888
-98% -$4.94M ﹤0.01% 5404
2025
Q3 		$5.16M Buy
62,898
+61,478
+4,329% +$4.43M ﹤0.01% 2649
2025
Q2 		$93K Buy
1,420
+1,263
+804% +$78.6K ﹤0.01% 5645
2025
Q1 		$11K Sell
157
-726
-82% -$49.2K ﹤0.01% 6113
2024
Q4 		$68K Sell
883
-4,107
-82% -$355K ﹤0.01% 5533
2024
Q3 		$417K Buy
4,990
+643
+15% +$42.8K ﹤0.01% 4234
2024
Q2 		$240K Buy
4,347
+3,057
+237% +$166K ﹤0.01% 4610
2024
Q1 		$90K Sell
1,290
-10,684
-89% -$678K ﹤0.01% 5241
2023
Q4 		$665K Buy
11,974
+6,994
+140% +$316K ﹤0.01% 4011
2023
Q3 		$179K Buy
4,980
+2,020
+68% +$69.6K ﹤0.01% 4908
2023
Q2 		$93K Buy
2,960
+1,260
+74% +$48.2K ﹤0.01% 5392
2023
Q1 		$52K Sell
1,700
-1,653
-49% -$50.1K ﹤0.01% 5597
2022
Q4 		$103K Buy
3,353
+2,957
+747% +$67.8K ﹤0.01% 5416
2022
Q3 		$8K Sell
396
-4,280
-92% -$81.9K ﹤0.01% 6510
2022
Q2 		$85K Buy
4,676
+3,117
+200% +$40.2K ﹤0.01% 5446
2022
Q1 		$22K Buy
+1,559
New +$26.1K ﹤0.01% 6544

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Royal Bank of Canada's ACLX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Arcellx (ACLX) stake by 94% in Q1 2026, selling an estimated $83.9K and leaving 59 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #6293.

Royal Bank of Canada first reported a position in ACLX in Q1 2022 and has held it in 17 quarters since. The position peaked at $5.16M in Q3 2025. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Royal Bank of Canada held 59 shares of Arcellx worth $7K as of Q1 2026.
  • Royal Bank of Canada sold 951 Arcellx shares in Q1 2026, an estimated $83.9K.
  • Arcellx made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6293 holding.
  • Royal Bank of Canada first reported a position in Arcellx in Q1 2022 and has held it in 17 quarters since.
  • Royal Bank of Canada's Arcellx position peaked at $5.16M in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.